Globus Medical第三季度业绩强劲并上调指引，盘后股价上涨10%
肌肉骨骼解决方案公司 Globus Medical Inc (NYSE:GMED)的股价在报告第三季度盈利超出分析师预期并上调全年指引后跃升7.4%。
该公司公布的调整后每股收益为0.83美元，超过分析师预期的0.65美元。季度收入达到6.257亿美元，同比增长63.1%，高于分析师预测的6.0471亿美元。
"我们的第三季度业绩反映了我们业务的持续强劲，"总裁兼首席执行官Dan Scavilla表示。"我们继续实现我们的业务目标，推动销售增长，推出新产品，并执行我们的整合计划，同时交付强劲的财务业绩。"
Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元，高于此前的2.80-2.90美元预期，也超过了华尔街2.85美元的共识预期。
公司全球净销售额的增长主要由NuVasive的加入推动，以及脊柱产品销售和使能技术产品及服务的销量增加。美国净销售额同比增长60.3%，而国际净销售额跃升74.8%。
首席运营官兼首席财务官Keith Pfeil评论道："我们在整个产品组合中实现了显著的销售增长，并产生了强劲的盈利增长，这些都在季度内创造了创纪录的运营和自由现金流结果，同时我们继续为长期发展进行投资。"
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10